LNSR
NASDAQ HealthcareLENSAR, Inc. - Common Stock
Medical Devices
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
๐ Market Data
| Price | $7.07 |
|---|---|
| Volume | 124,412 |
| Market Cap | 86.86M |
| Beta | 0.970 |
| RSI (14-Day) | 28.0 Oversold |
| 200-Day MA | $8.24 |
| 50-Day MA | $7.00 |
| 52-Week High | $12.94 |
| 52-Week Low | $4.95 |
| P/E Ratio | 35.35 |
| Forward P/E | -9.96 |
| Price / Book | 5.82 |
๐ฏ Investment Strategy Scores
LNSR scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (83/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Institutional Whale (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find LNSR in your text
Paste any article, transcript, or post โ the tool will extract LNSR and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-18.